Bruker Initiates Coverage with Buy Recommendation from Rothschild & Co

viernes, 21 de noviembre de 2025, 2:24 am ET1 min de lectura
BRKR--

Rothschild & Co initiates coverage of Bruker (BRKR) with a Buy recommendation. The average one-year price target is $47.46/share, a 8.28% increase from its latest closing price of $43.83/share. The projected annual revenue is 2,823MM, a decrease of 17.91%, and the projected annual non-GAAP EPS is 3.13. There are 809 funds or institutions reporting positions in Bruker, with an average portfolio weight of 0.18%.

Bruker Initiates Coverage with Buy Recommendation from Rothschild & Co

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios